Killer immunoglobulin-like receptor and their HLA ligands in Guillain-Barré Syndrome
Stefan Blum1, Peter Csurhes2, Stephen Reddel3
1Royal Brisbane and Women's Hospital, Department of Neurology, Herston, QLD 4029, Australia; University of Queensland, Centre of Clinical Research, Herston Campus, Herston, QLD 4029, Australia.
Abstract:
Guillain-Barré Syndrome (GBS) is an inflammatory neuropathy that occurs in some individuals after exposure to an infectious illness. We investigated the role of Killer-immunoglobulin-like receptors (KIR) and their HLA ligands as potential genetic factors in the pathogenesis of GBS. These receptors are involved in the innate immune response to infections. Whilst no significant differences in the frequencies KIR genes were found, HLA-C2 and HLA-B Bw4-T were more frequent in subjects with GBS than controls (p<0.001). The inhibitory pairs KIR-2DL2/HLA-C2 and KIR-3DL1/HLA-B Bw4-T were more frequent in GBS than controls (all p<0.005). We propose that NK cell inhibition is an important factor in the pathogenesis of GBS.
More Related Videos
Related Concept Videos
Myasthenia Gravis ll: Pathophysiology
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...


